PATENT CLAIM ANALYSIS

Application Number: 15986033
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "430000"]

Abstract:
A composition for prevention or treatment of pulmonary fibrosis comprising chromenone derivatives represented by Formula I of the present invention or pharmaceutically acceptable salts thereof as an active ingredient, produces altered heat shock protein 27 (HSP27) dimers, thereby preventing normal HSP27 non-phosphorylated polymers from performing a chaperone function and reducing a cell protection function that chaperone originally performs. Thus the inventive composition has a remarkable inhibitory effect on pulmonary fibrosis, in particular, an irradiation-induced pulmonary fibrosis phenomenon.

Claim (Index 2):
The method of  claim 1 , wherein R 1  and R 2  are each independently hydrogen,

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.26866
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13375217', '14317602', '14729969', '12309010', '13882363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7070101865346432
- 35 USC 102 Novelty (BERT): 0.5113927760810079
- Combined Prediction Score: 0.6874484454892796
- Mean Citation Score: 168.29004600000005
- Max Citation Score: 173.41737
- Similarity Product: 99.13771390651884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test